Strides Pharma Science shares worth Rs 69 crore exchange hands; stock falls over 1.5%
13.75 lakh shares of Strides Pharma Sciences changed hands, following which, the stock price sank over 1.5 percent06-10-2023
06-10-2023
Strides Pharma Science trades marginally lower despite USFDA nod
The company has received approval for Efavirenz (600mg), Emtricitabine (200mg), Tenofovir Disproxil Fumurate (300mg), (EET) tablets from the United States Food Drug Administration (USFDA).05-10-2023
Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Strides receives USFDA approval for Efavirenz, Emtricitabine & Tenofovir Disoproxil Fumurate tablets04-10-2023
Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Investor call transcript03-10-2023
Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)
This has reference to the Press Release issued by the Company on September 23, 2023 titled as ''Strides receives USFDA approval for Icosapent Ethyl Capsules''. The said press release has been updated with some additional information on the Product and the revised press release is attached herewith for your records.03-10-2023
Reduce Strides Pharma Science; target of Rs 495: ICICI Securities
ICICI Securities recommended reduce rating on Strides Pharma Science with a target price of Rs 495 in its research report dated September 26, 2023.27-09-2023
Strides Pharma share price falls over 3% on plans to spin off CDMO, gelatin biz into separate entity
Strides Pharma said its board has approved a scheme of arrangement among group entities to combine identified CDMO business of Strides, the identified CDMO business of Steriscience and the soft gelatin business under Stelis under one entity called OneSource.26-09-2023
Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio recording of Investors call held today, September 25, 202325-09-2023
Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Scheme of Arrangement
Scheme of Arrangement25-09-2023
Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Restructuring
Transaction amongst wholly-owned subsidiaries25-09-2023